Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism
- 1 January 1990
- journal article
- letter
- Published by Elsevier in Life Sciences
- Vol. 47 (18) , PL91-PL97
- https://doi.org/10.1016/0024-3205(90)90376-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortexPublished by Elsevier ,2002
- Role of N-methyl-d-aspartate (NMDA) receptors in experimental catalepsy in ratsLife Sciences, 1990
- Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkeyNeuropharmacology, 1989
- Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channelsEuropean Journal of Pharmacology, 1989
- Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineNeuroscience, 1989
- Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidusBrain Research, 1989
- Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivityBrain Research, 1988
- Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonistsEuropean Journal of Pharmacology, 1987
- ParkinsonismNeurology, 1967